$MGRX News

Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY

Mangoceuticals Stock Doubles After Texas Lawsuit

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.

Mangoceuticals shares are trading higher after the company announced it filed a lawsuit against Clarity Ventures.

Mangoceuticals Files Civil Lawsuit Against Clarity Ventures For $73M; Alleges Clarity Failed To Deliver Fully Functional HIPAA-Compliant Enterprise Resource Planning And eCommerce Platform

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Mangoceuticals shares are trading higher after the company announced it filed a Patent Cooperation Treaty international application to secure broad global patent protection for the antiviral animal feed and drinking water additive technology that powers MGX-0024.

Mangoceuticals Files PCT International Application To Secure Global Patent Protection For Antiviral Animal Feed And Drinking Water Additive Technology Powering MGX-0024

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Mangoceuticals Announces New Data From Its Proprietary Antiviral Compound MGX-0024

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

Mangoceuticals shares are trading higher after the company announced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy treatment program.

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Mangoceuticals Sees Initial Success With Launch Of Testosterone Replacement Therapy; Month-Over-Month Sales Climb 336% Since December Launch

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Mangoceuticals shares are trading lower. The company announced up to a $100 million Solana-focused digital asset treasury strategy.

Mangoceuticals Announces Up To $100M Solana-Focused Digital Asset Treasury Strategy In Partnership With Cube Group

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Mangoceuticals Announces $2.5M Registered Direct Offering, Selling 1.93M Common Units At $1.295 And Pre-Funded Units